Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad Medical Dialogues Bureau5 Aug 2019 4:15 AM GMTLupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US Mar...
Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm Medical Dialogues Bureau10 July 2019 4:34 AM GMTThe Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months e...
Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer Medical Dialogues Bureau10 July 2019 4:30 AM GMTLupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec T...
Cipla to acquire 11.71 percent stake in Wellthy Therapeutics Garima20 Feb 2019 9:25 AM GMTNew Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
